Established cell lines and primary cultures in testing medical devices in vitro. 1999

E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
Laboratory for Biocompatibility Research on Implant Materials, Istituti Ortopedici Rizzoli, Bologna, Italy.

In testing for the cytotoxicity of medical devices, crucial parameters are the type of cells, the duration of the exposure, the physical form of the device and the method of evaluation. Using cell cultures the changes of cell functions induced by artificial materials may be evaluated. In screening tests the effect of biomaterials on functions common to all cell types is investigated through both continuous lines and primary cultures. In supplementary tests the effect of biomaterials on specific functions is studied, employing cells of the same type of those which will be in contact with the device in vivo. Osteoblasts, either from primary culture or an established line, are used to study the interaction with materials for bone implants. We evaluated whether dental cements affect the replication cycle of osteoblast-like cells MG63. The S phase was inhibited by the cements with a phenolic group, even though to a different extent. Mononuclear cell cultures are used to investigate the immune response, which is important in the host reaction to implant. We investigated whether the chromium ions released in a biological fluid may induce PBMC to produce cytokines involved in bone resorption. Chromium extract did not impair TNFalpha release significantly, but inhibited IL-6 release significantly in stimulated PBMC. Endothelial cell cultures are useful to the evaluation of materials for vascular grafts. We studied the influence of some types of Dacron on endothelial functions. Collagen-coated Dacron decreased significantly the production of 6-keto-prostaglandin F(1alpha). Knitted Dacron caused a significant increase of tissue factor, a significant reduction in PECAM-1 and a significant increase in ELAM-1.

UI MeSH Term Description Entries

Related Publications

E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
December 1961, Experimental cell research,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
January 1978, Progress in clinical and biological research,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
November 1986, Biochemical and biophysical research communications,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
August 1986, International journal for parasitology,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
August 2002, The Journal of toxicological sciences,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
November 1993, Stem cells (Dayton, Ohio),
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
January 1985, Anticancer research,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
June 1997, The Histochemical journal,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
January 1991, Tissue & cell,
E Cenni, and G Ciapetti, and D Granchi, and C R Arciola, and L Savarino, and S Stea, and L Montanaro, and A Pizzoferrato
January 1990, Anticancer research,
Copied contents to your clipboard!